Bridging Therapy Prior to Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bridging Therapy Prior to Axicabtagene Ciloleucel for Relapsed/Refractory Large B-Cell Lymphoma
Blood Adv 2020 Jul 14;4(13)2871-2883, CC Pinnix, JR Gunther, BS Dabaja, P Strati, P Fang, MC Hawkins, S Adkins, J Westin, S Ahmed, L Fayad, HJ Lee, R Nair, RE Steiner, SP Iyer, MA Rodriguez, M Wang, C Flowers, SS Neelapu, LJ NastoupilFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.